Convocation of the 30 April 2019 General Meeting of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
31
Convocation of the 30 April 2019 General Meeting of Shareholders of Rokiskio suris AB

Upon initiative of the Board of Directors of Rokiskio suris AB and the resolution approved on 05/04/2019, on April 30, 2019, at 12:00 hrs it shall be summoned a General Meeting of Shareholders of Rokiskio suris AB (company code 173057512, registered address Pramonės str. 3, Rokiskis) to be held in the company’s head office (Pramonės str. 3, Rokiskis). Registration starts at 11:00 hrs and lasts until 11:45 hrs.

Accounting day of the general meeting of shareholders – April 23, 2019.

Record day – May 15, 2019.

Draft Agenda of the General Meeting of Shareholders:

1. Auditor’s findings regarding the consolidated financial reports and annual report. 2. The Audit Committee report. 3. The Company’s consolidated annual report for the year 2018. 4. Approval of the consolidated and company’s financial accounting for the year 2018. 5. Allocation of the profit (loss) of the Company of 2018. 6. Regarding purchase of own shares. 7. Election of the Company’s auditor and establishment of payment conditions.

The general meeting of shareholders may be attended and voted by the persons who were shareholders at the end of the meeting accounting date (April 23, 2019) or other persons authorized by actual shareholders, or the persons with whom the voting transference agreement was made.

Participants of the general meeting of shareholders with the voting right should have a document proving their identity. The person, who is not a shareholder, in addition should present a document proving his/her right to vote on the general meeting of shareholders. Each shareholder shall have a right, in the manner established by the Law, to authorise another (natural or legal) person on his/her behalf to attend and vote at the General Meeting of Shareholders. The authorised person must provide a power of attorney certified in the manner established by the Law. A power of attorney issued in a foreign state must be translated into Lithuanian and legalised in the manner established by the Law. At the General Meeting of Shareholders, an authorised person shall have the same rights as would be held by the shareholder represented by him/her. The Company does not establish special form of power of attorney. The right of shareholder to participate at the general meeting of shareholders also means the right to question.

A shareholder or a person authorised by him/her shall have a right to vote in writing in advance by filling in the General Voting Ballot. The General Voting Ballot shall be placed on the company’s website not later than 21 day before the General meeting http://www.rokiskio.com at the heading “Investor Relations”. Upon a shareholder's request, the Company, not later than 10 days before the General Meeting, shall send the General Voting Ballot by registered mail free of charge. The filled in General Voting Ballot and the document confirming the voting right (if any) must be submitted to the Company in writing not later than on the last business day before the General Meeting of Shareholders by sending it by registered mail to AB „Rokiskio suris“, Pramones street 3, Rokiskis LT-42150. The Company keeps the right to not account a shareholder’s General Voting Ballot if the General Voting Ballot does not comply with the requirement set by the Law on Joint Stock Companies Article 30 parts 3 and 4, or the ballot is filled misleadingly and it is impossible to read the shareholder’s will for one or another item.

The Company is not providing the possibility to attend and vote at the General Meeting of Shareholders through electronic means of communication.

Each shareholder holding shares that grant at least 1/20 of all votes shall have the right of proposing to supplement the agenda of the General Meeting of Shareholders. Draft decisions on the proposed issues shall be submitted together with the proposal or, if the decisions do not need to be approved, explanations on each proposed issue of the General Meeting of Shareholders shall be presented. Proposal to supplement the agenda must be presented in writing by sending it by registered mail to AB „Rokiskio suris“, Pramones street 3, Rokiskis LT-42150, Lithuania, or by e-mail rokiskio.suris@rokiskio.com. The agenda will be supplemented if the proposal is received not later than 14 days before the General Meeting of Shareholders.

Each shareholder holding shares that grant at least 1/20 of all votes shall have the right of proposing draft resolutions on the issues already included in the agenda of the General Meeting of Shareholders, as well as to nominate additional candidates to the company’s management bodies. The proposed draft decisions must be presented in writing by sending them by registered mail to AB „Rokiskio suris“, Pramones street 3, Rokiskis LT-42150, Lithuania, or by e-mail rokiskio.suris@rokiskio.com. The shareholders shall also be entitled to propose draft resolutions on the agenda issues of the General Meeting of Shareholders during the Meeting.

The shareholders shall have the right to present questions related to the agenda issues of the General Meeting of Shareholders to the Company in advance in writing. The questions should be sent by e.mail address rokiskio.suris@rokiskio.com  not later than 3 business days before the General Meeting of Shareholders. The Company will not respond personally to the shareholder if the respective information is posted on the Company's website. The Company may refuse to respond to the questions of a shareholder if they are related with the commercial (manufacturing) secret, confidential information, then the shareholder will be informed unless the identity of questioner cannot be identified.

The shareholders could get familiarised with the documents possessed by the Company related to the agenda of the Meeting, including draft resolutions, and other documents to be submitted to the General Meeting of Shareholders as well as to get information regarding execution of the shareholders' rights at the headquarters of AB „Rokiskio suris“, Pramones street 3, Rokiskis LT-42150, Lithuania, or on the company’s website www.rokiskio.com under the heading ‘Investor Relations'.

The total number of shares is 35,867,970 ordinary registered shares. Nominal value of the shares is EUR 0.29 each. ISIN of the Company’s shares is LT000100372. Number of the shares with voting right – 35,061,653. The Company has purchased 806,317 treasury shares.

Dalius Trumpa Company Manager +370 458 55200

Attachments

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading